Ferenc Balázs Farkas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ferenc Balázs Farkas has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Giacomo Guido
Department of Precision and Regenerative Medicine and Jonian Area (DiMePreJ), Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, BA, Italy
3 shared publications Annalisa Saracino
Clinic of Infectious and Tropical Diseases, Department of Precision and Regenerative Medicine and Jonian Area (DiMePRe-J), University of Bari "Aldo Moro", Bari, Italy
2 shared publications- Emanuele Nicastri
National Institute for Infectious Diseases “Lazzaro Spallanzani” IRCCS, Rome, Italy
2 shared publications Francesco Di Gennaro
Clinic of Infectious and Tropical Diseases, Department of Precision and Regenerative Medicine and Jonian Area (DiMePRe-J), University of Bari "Aldo Moro", Bari, Italy
2 shared publications- Francesco Di Gennaro
Clinic of Infectious Diseases, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, 70124 Bari, Italy
2 shared publications - Muhammad Asaduzzaman
Department of Community Medicine and Global Health, Institute of Health and Society, Faculty of Medicine, University of Oslo
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 117 (1)
Congenital syphilis as a failure of the maternal–fetal prevention cascade: Clinical implications for pregnant migrant and structurally vulnerable women in high-income settings — an ESCMID study group for infections in Travellers and migrants (ESGITM) perspective
- 30 September 2026
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 117 (1)
Open AccessCongenital syphilis as a failure of the maternal–fetal prevention cascade: Clinical implications for pregnant migrant and structurally vulnerable women in high-income settings — an ESCMID study group for infections in Travellers and migrants (ESGITM) perspective
- Open Access
- 15 January 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (1) , 12
Addressing Infectious Diseases in Vulnerable Populations Under the Auspices of One Health: A Call for Action in Europe
While infectious diseases represent a daunting challenge to public health worldwide, their impact is disproportionately felt among the most vulnerable and marginalized segments of society
- 15 January 2026
- Published by MDPI AG in Infectious Disease Reports
- Vol. 18 (1) , 12
Open AccessAddressing Infectious Diseases in Vulnerable Populations Under the Auspices of One Health: A Call for Action in Europe
While infectious diseases represent a daunting challenge to public health worldwide, their impact is disproportionately felt among the most vulnerable and marginalized segments of society
- Open Access
- 18 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Third-generation Cephalosporin resistance in Sub-Saharan Africa: a systematic review and meta-analysis
Background Antimicrobial resistance is a critical global health threat, with Sub-Saharan Africa disproportionately affected. Third-generation cephalosporins are widely used for severe infections due to their safety, broad spectrum, and effectiveness. However, resistance to third-generation cephalosporins undermines treatment and exacerbates poor outcomes in regions with limited alternative therapies. This systematic review and meta-analysis evaluated the prevalence, temporal trends, and geographical variations of resistant pathogens in Sub-Saharan Africa. Methods We searched three databases from the inception until 16th August 2024 for observational studies reporting third-generation cephalosporin resistant infections in Sub-Saharan Africa. Eligible studies reported prevalence data for confirmed infections in SSA. Pooled prevalence estimates with 95% confidence intervals (CIs) were calculated using random-effects meta-analysis, with subgroup analyses by pathogen, region, clinical setting, and publication year. Results Here we show a total of 200 studies involving 355,136 patients. The pooled prevalence of third-generation cephalosporin resistant pathogens is 45.3% (95% CI: 36.7–54.4%). Resistance rates are highest for Klebsiella pneumoniae (57.7%) and Enterobacter spp. (54.2%). Temporal trends show an increase in resistance, with prevalence rising from 22.8% before 2009 to 42.0% in 2020–2024. Geographical disparities are evident, with higher prevalence in East (59.7%) and West Africa (49.8%) compared to Central Africa (27.0%). High-risk settings include neonatal intensive care units, surgical wards, and rural or mixed-care facilities. Conclusions Third-generation cephalosporin resistant pathogens represent an escalating global health crisis in SSA, exacerbated by regional disparities and rising resistance rates over time. Immediate interventions are needed, including enhanced surveillance and antimicrobial stewardship programs.
- 18 November 2025
- Published by Springer Nature in Communications Medicine
- Vol. 6 (1)
Open AccessThird-generation Cephalosporin resistance in Sub-Saharan Africa: a systematic review and meta-analysis
Background Antimicrobial resistance is a critical global health threat, with Sub-Saharan Africa disproportionately affected. Third-generation cephalosporins are widely used for severe infections due to their safety, broad spectrum, and effectiveness. However, resistance to third-generation cephalosporins undermines treatment and exacerbates poor outcomes in regions with limited alternative therapies. This systematic review and meta-analysis evaluated the prevalence, temporal trends, and geographical variations of resistant pathogens in Sub-Saharan Africa. Methods We searched three databases from the inception until 16th August 2024 for observational studies reporting third-generation cephalosporin resistant infections in Sub-Saharan Africa. Eligible studies reported prevalence data for confirmed infections in SSA. Pooled prevalence estimates with 95% confidence intervals (CIs) were calculated using random-effects meta-analysis, with subgroup analyses by pathogen, region, clinical setting, and publication year. Results Here we show a total of 200 studies involving 355,136 patients. The pooled prevalence of third-generation cephalosporin resistant pathogens is 45.3% (95% CI: 36.7–54.4%). Resistance rates are highest for Klebsiella pneumoniae (57.7%) and Enterobacter spp. (54.2%). Temporal trends show an increase in resistance, with prevalence rising from 22.8% before 2009 to 42.0% in 2020–2024. Geographical disparities are evident, with higher prevalence in East (59.7%) and West Africa (49.8%) compared to Central Africa (27.0%). High-risk settings include neonatal intensive care units, surgical wards, and rural or mixed-care facilities. Conclusions Third-generation cephalosporin resistant pathogens represent an escalating global health crisis in SSA, exacerbated by regional disparities and rising resistance rates over time. Immediate interventions are needed, including enhanced surveillance and antimicrobial stewardship programs.